Difference between revisions of "Stakeholder Contacts"
| Line 3: | Line 3: | ||
The '''[[Public Comment Process]]''' benefits significantly from getting feedback from a variety of '''[[Stakeholder Viewpoints|different stakeholder groups]]'''. | The '''[[Public Comment Process]]''' benefits significantly from getting feedback from a variety of '''[[Stakeholder Viewpoints|different stakeholder groups]]'''. | ||
| − | This page is intended to collect names and contact information to facilitate outreach during any [[Profile Stages|Stage]] but especially during Public Comment. | + | This page is intended to collect names and contact information to facilitate outreach during any [[QIBA Profile Stages|Stage]] but especially during Public Comment. |
===[[QIBA for Radiologists|Radiologists]]=== | ===[[QIBA for Radiologists|Radiologists]]=== | ||
| + | (Primarily relevant clinical imaging sub-specialty professional organizations) | ||
===[[QIBA for Technologists|Technologists]]=== | ===[[QIBA for Technologists|Technologists]]=== | ||
| Line 15: | Line 16: | ||
===[[QIBA for Imaging Vendors|Imaging Vendors]]=== | ===[[QIBA for Imaging Vendors|Imaging Vendors]]=== | ||
| − | MITA (Medical Imaging Technology Alliance) | + | MITA (Medical Imaging Technology Alliance) https://www.medicalimaging.org |
:* Contact: | :* Contact: | ||
:* MITA has specific "sections" for different modalities. Typically QIBA should target the relevant section. | :* MITA has specific "sections" for different modalities. Typically QIBA should target the relevant section. | ||
| Line 37: | Line 38: | ||
===[[QIBA for Clinical Trials|Clinical Trials]]=== | ===[[QIBA for Clinical Trials|Clinical Trials]]=== | ||
| + | IROC (Imaging and Radiation Oncology Clinical Trial Quality Assurance) https://www.irocqa.org/ | ||
| + | :* Contact | ||
| + | |||
| + | Pintad (Pharma Imaging Network for Therapeutics and Diagnostics) https://www.pintad.net/ | ||
| + | :* Contact | ||
===Other Organizations=== | ===Other Organizations=== | ||
Revision as of 16:19, 18 August 2020
The Public Comment Process benefits significantly from getting feedback from a variety of different stakeholder groups.
This page is intended to collect names and contact information to facilitate outreach during any Stage but especially during Public Comment.
Radiologists
(Primarily relevant clinical imaging sub-specialty professional organizations)
Technologists
AIUM (American Institute of Ultrasound in Medicine) includes technologists.
- Profile evaluation would likely go to the Technical Standards Committee, but should also go to the Clinical Standards Committee.
- Contact:
Imaging Vendors
MITA (Medical Imaging Technology Alliance) https://www.medicalimaging.org
- Contact:
- MITA has specific "sections" for different modalities. Typically QIBA should target the relevant section.
COCIR (European Trade Association representing the medical imaging, radiotherapy, health ICT and electromedical industries)
- Contact:
JIRA (Japan Medical Imaging and Radiological Systems Industries Association)
- Contact:
Statisticians
Regulators
Physicists
AAPM (American Association of Physicists in Medicine)
- CT Profile review has been coordinated by Dr. Cynthia McCollough
Core Labs
Clinical Trials
IROC (Imaging and Radiation Oncology Clinical Trial Quality Assurance) https://www.irocqa.org/
- Contact
Pintad (Pharma Imaging Network for Therapeutics and Diagnostics) https://www.pintad.net/
- Contact
Other Organizations
EIBALL (European Imaging Biomarkers Alliance)
- Contact:
J-QIBA (Japanese Quantitative Imaging Biomarkers Alliance)
- Contact: